Dave Muoio

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum.

The fitness apparel brand said it will be throwing all its weight behind the MapMyFitness platform in an effort to better focus its digital strategy.

Newly published data from Scripps' DETECT study included data from 30,529 device owners, although only 333 of those who were symptomatic also provided their COVID-19 testing results.

Also: Vocalis Health and Mayo Clinic seek new pulmonary hypertension biomarkers; Sensyne Health and Microsoft's strategic partnership focuses on clinical AI co-development.

While the virtual care company maintains its momentum through the pandemic and Livongo merger, it also reported higher-than-expected losses during the quarter.

An annual review of state and federal laws regarding behavioral or mental health telemedicine highlights increased interest in the modality from policymakers and regulators.

The company handles back-office operations for its partner organizations, and provides professional caregivers with an app for finding and scheduling jobs.

Medidata said the deal will help better integrate clinical-grade metrics into its remote trial platform and broadly support the use of wearable sensors for clinical research.

Following news that its Project Baseline program was poorly received in parts of the Bay Area, the life science company characterized site closures as more of a pause and a redirection of resources across the state.

Researchers say that their tool detected cases with 79% accuracy, and did so within minutes.